乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

TCT

<乌鸦传媒>TCT: For Heart Devices, Will Lag Moving from Europe to U.S. Wane?

FDA Commissioner and E.U. representative talk change

<乌鸦传媒>TCT: Embolic Protection Flops for TAVR

New brain lesions or clinical strokes unaffected in SENTINEL trial

<乌鸦传媒>TCT: Trials Split on PCI vs CABG for Left Main Disease

NOBLE hands advantage to surgery, EXCEL finds noninferiority

<乌鸦传媒>TCT: Advantage of Novel DES Over BMS Grows With Time

For high bleeding risk patients, rationale for BMS continues to shrink

<乌鸦传媒>CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Underpowered IMPRESS trial shows no mortality benefit

<乌鸦传媒>TCT: OCT Guidance Doesn't Undersize Stents, Trial Shows

Also found dissection, malapposition that IVUS missed

<乌鸦传媒>TCT: Valve Leaflet Thrombosis 'Not Stent Thrombosis All Over Again'

Keep calm and leave it to the researchers, panel says

<乌鸦传媒>TCT: Drug-Coated PAD Balloon Results Durable

Superiority maintained at 2 years in IN.PACT SFA trial

<乌鸦传媒>TCT: Radial Access Safer in Ad Hoc PCI

Randomized trial shows similar efficacy, less bleeding

<乌鸦传媒>TCT: PFO No Panacea for Migraine

WASHINGTON -- Percutaneous patent foramen ovale (PFO) closure did not significantly reduce the number of monthly migraine days compared with medical treatment, researchers reported here.

<乌鸦传媒>TCT: Tablet Experiment Lightens Load at Meeting

SAN FRANCISCO -- Welcome to medical meeting 2.0: where the program is delivered via "App" displayed on Samsung tablets that come with the price of admission -- it's TCT 2013.

<乌鸦传媒>TCT: Removing Clot During PCI Fails in NSTEMI

SAN FRANCISCO -- Aspiration thrombectomy during percutaneous coronary intervention (PCI) did not improve outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI), a randomized trial showed.

<乌鸦传媒>TORPEDO Trial: Mohsen Sharifi, MD

WASHINGTON -- In this exclusive press conference, Dr. Sharifi presents a prospective randomized trial of percutaneous endovenous intervention compared to anticoagulation alone in patients with deep venous thrombosis.

<乌鸦传媒>COMPARE Trial: Peter C. Smits, MD, PhD

WASHINGTON -- In this exclusive press conference, Dr. Smits presents two-year results from a prospective randomized trial of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.